3-Quinolinecarboxamide, 1-cyclopropyl-6-fluoro-N-[5-[[(2-fluorophenyl)methyl]thio]-1,3,4-thiadiazol-2-yl]-1,4-dihydro-4-oxo-7-(1-piperazinyl)- manufacturers
|
| | 3-Quinolinecarboxamide, 1-cyclopropyl-6-fluoro-N-[5-[[(2-fluorophenyl)methyl]thio]-1,3,4-thiadiazol-2-yl]-1,4-dihydro-4-oxo-7-(1-piperazinyl)- Basic information |
| | 3-Quinolinecarboxamide, 1-cyclopropyl-6-fluoro-N-[5-[[(2-fluorophenyl)methyl]thio]-1,3,4-thiadiazol-2-yl]-1,4-dihydro-4-oxo-7-(1-piperazinyl)- Chemical Properties |
| density | 1.53±0.1 g/cm3(Predicted) | | pka | 5.75±0.50(Predicted) |
| | 3-Quinolinecarboxamide, 1-cyclopropyl-6-fluoro-N-[5-[[(2-fluorophenyl)methyl]thio]-1,3,4-thiadiazol-2-yl]-1,4-dihydro-4-oxo-7-(1-piperazinyl)- Usage And Synthesis |
| Uses | Anticancer agent 67 (Compound 13g) is an anti-cancer agent. Anticancer agent 67 induces apoptosis and increases sub-G1 cell population in MCF-7 cells. Anticancer agent 67 is a ciprofloxacin analog[1]. | | References | [1] Ahadi H, et al. Synthesis and biological assessment of ciprofloxacin-derived 1,3,4-thiadiazoles as anticancer agents. Bioorg Chem. 2020;105:104383. DOI:10.1016/j.bioorg.2020.104383 |
| | 3-Quinolinecarboxamide, 1-cyclopropyl-6-fluoro-N-[5-[[(2-fluorophenyl)methyl]thio]-1,3,4-thiadiazol-2-yl]-1,4-dihydro-4-oxo-7-(1-piperazinyl)- Preparation Products And Raw materials |
|